CLINICAL TRIALS PROFILE FOR XERESE
✉ Email this page to a colleague
All Clinical Trials for XERESE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01574612 ↗ | Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old | Completed | TKL Research, Inc. | Phase 3 | 2012-03-01 | To test the safety of Xerese (acyclovir and hydrocortisone)Cream 5%/1% for the treatment of recurrent cold sores in children ages 6-11yrs after 5 days of treatment. |
NCT01574612 ↗ | Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old | Completed | Meda Pharmaceuticals | Phase 3 | 2012-03-01 | To test the safety of Xerese (acyclovir and hydrocortisone)Cream 5%/1% for the treatment of recurrent cold sores in children ages 6-11yrs after 5 days of treatment. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for XERESE
Condition Name
Clinical Trial Locations for XERESE
Trials by Country
Clinical Trial Progress for XERESE
Clinical Trial Phase
Clinical Trial Sponsors for XERESE
Sponsor Name